Sign in

CIK 0001750149

  • Non-accelerated filer
  • Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263407249
Phone
+1 302-295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy President and CEO bought 5,000 shares at $0.98 ($4,880)
  6. 4 Open-market buy President and CEO bought 10,000 shares at $0.60 ($6,000)
  7. 4 Open-market buy Chief Financial Officer bought 3,948 shares at $0.64 ($2,543)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Exercise or conversion President and CEO acquired 21,853 shares (option exercise)
  13. 4 Open-market buy President and CEO bought 23,589 shares at an average $1.97 ($46,558)
  14. 4 Exercise or conversion President and CEO acquired 21,853 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Shares withheld for taxes President and CEO gave up 16,918 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 5 of 6 · 112 filings